Carlos Osmon is an expert in the field of Oncology. He received awards:"Meaningful Use Stage 1 Certification". Carlos Osmon is also published. He has 1 publication published. The lastest publication: "Phase II trial of 5-fluorouracil, folinic acid and recombinant alpha-2a-interferon in patients with advanced colorectal cancer.' Dr. Carlos A. Osmon accepts all Medicare patients.
NPI NUMBER | 1225033640 | |
NPPES Provider LastName | OSMON | |
NPPES Provider FirstName | CARLOS | |
NPPES Provider ZIPCode | 301068116 | |
NPPES Provider State | GA | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 624.0 | |
Distinct Opioid Count | 3.0 | |
Opioid Claim Count | 69.0 | |
Percent Opioid Claims | 11.06 |
National Provider Identifier [NPI] | 1225033640 |
Last Name Of The Provider | OSMON |
First Name Of The Provider | CARLOS |
View All |
Dr. Raul H. Oyola, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Navin P. Wadehra, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Sujatha Hariharan, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Alaa-El-Din Soltan, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Philip Z. Israel, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Marla Franks, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Debora Miller, MD | |
Dr. Deepti A. Munjal, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. John T. Zimmermann, MD |